Fluvoxamine Maleate Capsule, Extended Release
Product Images NDC 73190-067

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fluvoxamine Maleate (NDC 73190-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 (066 30)

Fluvoxamine Maleate Extended-Release Capsules 100 mg in a bottle label from AvKARE. The label indicates a once-a-day dosage, contains 30 capsules, and specifies the capsules are prescription-only. It includes instructions not to crush or chew capsules and notes the product is manufactured for AvKARE in Winston Salem, NC.*

FDA Label Image

2 (067 30)

Fluvoxamine Maleate Extended-Release Capsules 150 mg by AvKARE displayed on a white and red label. The label indicates once-a-day dosing and contains warnings to dispense the accompanying Medication Guide. It specifies that each extended-release capsule contains 150 mg and includes storage instructions to keep the capsules in a tight, light-resistant container at 20° to 25°C. The package contains 30 capsules and is marked Rx Only.*

FDA Label Image

Ebfb06fd-figure-01 (Image 1)

Fluvoxamine Maleate extended release capsules in two available strengths: 100 mg and 150 mg. The image shows a carton packaging label with the AvKARE labeler name. The dosage form is oral capsules, as indicated on the label.*

FDA Label Image

Ebfb06fd-figure-02 (Image 2)

Fluvoxamine Maleate extended-release capsule blister pack labeled with a strength of 150 mg, containing capsules arranged in a single row. The labeler is AvKARE, and the packaging includes a 30-count configuration, with each capsule sealed individually in the blister.*

FDA Label Image

Ebfb06fd-figure-03 (Image 3)

Chemical structure of Fluvoxamine Maleate showing its molecular formula with a trifluoromethyl-substituted aromatic ring and the maleate component represented by two carboxylic acid groups.*

FDA Label Image

Ebfb06fd-figure-04 (Image 4)

Fluvoxamine Maleate extended release capsules in 100 mg strength, presented in a white and silver blister pack. The packaging shows 7 capsules with imprint visible, labeled by AvKARE for oral use, with product name and strength on the blister pack.*

FDA Label Image

Ebfb06fd-figure-05 (Image 5)

Fluvoxamine Maleate extended-release capsule label showing 150 mg strength. The label includes identifying code and is manufactured by AvKARE. The capsule is depicted with a bicolor design and legible imprints.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.